[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367073-105":59,"doc-detail-367073-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-setd4-as-an-onco-immunological-biomarker-encompassing-the-tumor-microenvironment-prognoses-and-therapeutic-responses-in-various-human-cancers","Identification of SETD4 as an Onco-Immunological Biomarker Encompassing the Tumor Microenvironment, Prognoses, and Therapeutic Responses in Various Human Cancers","","SETD4 is a histone methyltransferase involved in regulating proliferation, differentiation, and inflammatory signaling through H4K20me3. Prior studies link SETD4 to cancer stem cell quiescence and drug resistance, but its systematic roles across tumor microenvironment, pathogenesis, prognosis, and therapy response remain insufficiently clarified. Using TCGA and public resources, investigators assess expression, methylation, prognostic value, immune microenvironment and immunotherapy markers, chemotherapy resistance signatures, and validate SETD4 expression by qRT-PCR in clinical specimens.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-setd4-as-an-onco-immunological-biomarker-encompassing-the-tumor-microenvironment-prognoses-and-therapeutic-responses-in-various-human-cancers/367073/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-setd4-as-an-onco-immunological-biomarker-encompassing-the-tumor-microenvironment-prognoses-and-therapeutic-responses-in-various-human-cancers/367073.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is SETD4 and why is it considered important in cancer research?","Question",{"text":112,"@type":113},"SETD4 is a histone methyltransferase that regulates cell proliferation, differentiation, and inflammatory responses via histone H4 trimethylation (H4K20me3). Prior findings also connect it to cancer stem cell quiescence and drug resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the study evaluate SETD4’s relationship with tumors?",{"text":117,"@type":113},"The analysis uses TCGA and other public platforms to examine SETD4 expression, methylation patterns, prognostic significance, immune microenvironment features, immunotherapy markers, and chemotherapy drug-resistance signatures. qRT-PCR validates SETD4 expression in clinical specimens.",{"name":119,"@type":110,"acceptedAnswer":120},"What findings link SETD4 to prognosis and the tumor microenvironment?",{"text":121,"@type":113},"SETD4 expression shows abnormal patterns across multiple cancers, with colorectal cancer validation in clinical specimens. Upregulation associates with worse overall survival and progression-free survival, promoter methylation relates to survival, and SETD4 negatively impacts immune cell infiltration in many cancers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367073,1790985989,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Immunity, Inflammation and Disease  \nORIGINAL ARTICLE   \nIdentification of SETD4 as an Onco‐Immunological Biomarker Encompassing the Tumor Microenvironment, Prognoses, and Therapeutic Responses in Various Human Cancers  \nYuyun Zhong1,2 | Ruiqi Wang3 | Zijie Huang4 | Zhaoting Hu1 | Bin Peng5 | Bin Chen1,2 | Liyue Sun6   \n1Department of Health Management Center, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China | 2The Guangzhou Bay Area Institute of Biomedicine, Guangzhou, China | 3Department of Pharmacy, Zhuhai People's Hospital, Zhuhai Hospital Affiliated With Jinan University, Zhuhai, China | 4Department of Plastic Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, Guangdong, China | 5Department of Thoracic Surgery, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen People's Hospital, Shenzhen, China | 6Second Department of Oncology, Guangdong Second Provincial General Hospital, Guangzhou, China  \nCorrespondence: Bin Peng ([183672297@qq.com](183672297@qq.com)) | Bin Chen ([237525970@qq.com](237525970@qq.com)) | Liyue Sun ([plaz45@126.com](plaz45@126.com))  \nReceived: 11 June 2024 | Revised: 24 November 2024 | Accepted: 3 January 2025  \nFunding: This research was supported by the National Natural Science Foundation of China (Nos. 82102263, 82302640 and 82303902), the China Postdoctoral Science Foundation funded project (No. 2021M690776), the Xiangshan Talented Scientific Research Project of Zhuhai People's Hospital (No. 2021XSYC‐02), Guangzhou Science and Technology Plan Project (No. 2023A04J1129), Guangdong Medical Scientific Research (No. B2023038), Shanghai Rehabilitation Medicine Association Health Management Special Fund Project (No. 2024JGYQ11), and the Traditional Chinese Medicine Research Project of the Guangdong Provincial Bureau of Traditional Chinese Medicine (No. 20241293) .  \nKeywords: cancer stemness | pancancer | prognosis | SETD4 | tumor microenvironment  \nABSTRACT  \nBackground: SET domain‐containing protein 4 (SETD4) is a histone methyltransferase that has been shown to modulate cell proliferation, differentiation, and inflammatory responses by regulating histone H4 trimethylation (H4K20me3) . Previous reports have demonstrated its function in the quiescence of cancer stem cells as well as drug resistance in several cancers. A limited number of systematic studies have examined SETD4's role in the tumor microenvironment, pathogenesis, prognosis, and therapeutic response.  \nMethods: Utilizing The Cancer Genome Atlas database, and other publicly accessible platforms, we comprehensively analyzed SETD4 gene expression, methylation patterns, and prognostic significance. Furthermore, we investigated its association with cancer‐related pathways, the immune microenvironment, immunotherapy markers, and drug resistance signatures of chemotherapy. Additionally, qRT‐PCR was performed to validate SETD4 expression in clinical specimens.  \nResults: The expression of SETD4 was abnormal across a variety of cancer types and the expression of SETD4 in colorectal cancer tissues was verified in clinical specimens. The upregulation of SETD4 may be a prognostic risk factor predicting poor overall survival and progression‐free survival. The analysis revealed that the mRNA level of SETD4 was modulated by promoter methylation, and patients with lower methylation levels showed shorter survival times. Pathway analysis showed that SETD4 influenced several key cell cycle pathways, including the G2M checkpoint, and mitotic spindle pathways. In addition, SETD4 negatively affects immune cell infiltration in most cancers, including B cells, CD8 T cells, and macrophages. The correlation  \n\n| Yuyun Zhong, Ruiqi Wang and Zijie Huang contributed equally to this work. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the ","cbCaikHJqjTRIZ8o","https://ap.wps.com/l/cbCaikHJqjTRIZ8o","pdf",6438741,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is SETD4 and why is it considered important in cancer research?\",\"answer\":\"SETD4 is a histone methyltransferase that regulates cell proliferation, differentiation, and inflammatory responses via histone H4 trimethylation (H4K20me3). Prior findings also connect it to cancer stem cell quiescence and drug resistance.\"},{\"question\":\"How does the study evaluate SETD4’s relationship with tumors?\",\"answer\":\"The analysis uses TCGA and other public platforms to examine SETD4 expression, methylation patterns, prognostic significance, immune microenvironment features, immunotherapy markers, and chemotherapy drug-resistance signatures. qRT-PCR validates SETD4 expression in clinical specimens.\"},{\"question\":\"What findings link SETD4 to prognosis and the tumor microenvironment?\",\"answer\":\"SETD4 expression shows abnormal patterns across multiple cancers, with colorectal cancer validation in clinical specimens. Upregulation associates with worse overall survival and progression-free survival, promoter methylation relates to survival, and SETD4 negatively impacts immune cell infiltration in many cancers.\"}]","Identification of SETD4 as an Onco-Immunological Biomarker Encompassing the Tumor Microenvironment, Prognoses, and Therapeutic Responses in Various Human Cancers | PDF",1790169138,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82254f500fed2710bc15b29ed94c7cf6.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66899f2b0365292851679796b3de7d00.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d67d1480123cbd719c3966906a579dd.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33e6f2a92743e2dd459f2eeb0c7c34e9.webp",980,1287]